1-3 of 3
Rolf Brouwer
Close
Sort by
Journal Articles

Frailty Predicts Survival and Toxicity in Newly Diagnosed Multiple Myeloma Patients Ineligible for Autologous Stem Cell Transplantation; Report of the HOVON-87/Nmsg-18 Study Group

Claudia A.M. Stege, MD, Bronno van der Holt, Ulf-Henrik Mellqvist, MD, Mark-David Levin, PhD, Morten Salomo, Niels Abildgaard, MD, Gerard Bos, MDPhD, Heleen Visser-Wisselaar, Markus Hansson, MD PhD, Annette van der Velden, MD, Wendy Deenik, MD, Astrid Gruber, MD PhD, Jules L.L.M. Coenen, MD, Torben Plesner, MD, Saskia Klein, MD, Bea Tanis, MD PhD, Damian L. Szatkowski, MDPhDMSc, Rolf Brouwer, MD PhD, Matthijs Westerman, MD, Maria Berhardina Leijs, MD, Harm Sinnige, Einar Haukaas, Klaas van der Hem, MD PhD, Marc Durian, MD, Vera Mattijssen, MD PhD, Peter Gimsing, DO, PhD, Niels WCJ Van De Donk, Marian Stevens-Kroef, PhD, Pieter Sonneveld, MDPhD, Anders Waage, MD PhD, Sonja Zweegman, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3146.
https://doi.org/10.1182/blood.V130.Suppl_1.3146.3146
Published: 2017
Journal Articles

Randomized Phase III Trial in Non-Transplant Eligible Patients with Newly Diagnosed Symptomatic Multiple Myeloma Comparing Melphalan-Prednisone-Thalidomide Followed By Thalidomide Maintenance (MPT-T) Versus Melphalan-Prednisone-Lenalidomide Followed By Maintenance with Lenalidomide (MPR-R); A Joint Study of the Dutch-Belgian Cooperative Trial Group for Hematology Oncology (HOVON) and the Nordic Myeloma Study Group (NMSG)

Sonja Zweegman, MDPhD, Bronno van der Holt, PhD, Ulf-Henrik Mellqvist, MDPhD, Morten Salomo, MD, Gerard M.J. Bos, MDPhD, Mark-David Levin, MDPhD, Heleen A Visser-Wisselaar, PhD, Markus Hansson, MD PhD, Annette WG van der Velden, MD, Wendy Deenik, MDPhD, Astrid Gruber, MDPhD, Juleon LLM Coenen, MD, Torben Plesner, MD, Saskia K Klein, MDPhD, Bea Tanis, MDPhD, Damian L Szatkowski, MDPhDMSc, Rolf Brouwer, MDPhD, Matthijs Westerman, MD, M (Rineke) BL Leys, MDPhD, Niels W.C.J. van de Donk, MDPhD, Einar Haukås, MD, Klaas van der Hem, MD PhD, MF Durian, MD, E (Vera) JM Mattijssen, MDPhD, Harm AM Sinnige, MDPhD, Marian JPL Stevens-Kroef, PhD, Pieter Sonneveld, MDPhD, Anders Waage, MD PhD
Journal: Blood
Blood (2014) 124 (21): 179.
https://doi.org/10.1182/blood.V124.21.179.179
Published: 2014
Journal Articles

Platelet Doubling After the First Azacitidine Cycle Is a Promising Predictor for Response in MDS, CMML and AML Patients in the Dutch Azacitidine Compassionate Patient Named Program,

Geert A Huls, Lieke H. van der Helm, Canan Alhan, P.W. Wijermans, MD, PhD, Marinus van Marwijk Kooy, Martijn R. Schaafsma, Bart J Biemond, MD, Aart Beeker, Mels Hoogendoorn, Bastiaan P. van Rees, Okke de Weerdt, Jurgen Wegman, Eduard J Libourel, Sylvia A. Luykx-de Bakker, Monique C. Minnema, MD PhD, Rolf Brouwer, Fransien Croon-de Boer, Matthias Eefting, Kon-Siong G. Jie, Arjan A. van der Loosdrecht, Jan Koedam, Nic J.G.M. Veeger, Edo Vellenga, PhD
Journal: Blood
Blood (2011) 118 (21): 3841.
https://doi.org/10.1182/blood.V118.21.3841.3841
Published: 2011